Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$40.38 - $50.75 $2.03 Million - $2.55 Million
50,302 New
50,302 $2.49 Million
Q4 2023

Feb 14, 2024

SELL
$24.89 - $43.41 $3.5 Million - $6.11 Million
-140,678 Reduced 30.37%
322,581 $13.5 Million
Q3 2023

Nov 14, 2023

BUY
$30.02 - $38.81 $3.9 Million - $5.04 Million
129,973 Added 39.0%
463,259 $15.2 Million
Q2 2023

Aug 14, 2023

BUY
$26.7 - $37.02 $8.9 Million - $12.3 Million
333,286 New
333,286 $11.8 Million
Q3 2022

Nov 14, 2022

SELL
$30.9 - $50.65 $1.85 Million - $3.03 Million
-59,857 Reduced 38.13%
97,143 $4.03 Million
Q2 2022

Aug 15, 2022

BUY
$29.23 - $44.45 $4.59 Million - $6.98 Million
157,000 New
157,000 $5.13 Million

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $3.62B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Polar Asset Management Partners Inc. Portfolio

Follow Polar Asset Management Partners Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polar Asset Management Partners Inc., based on Form 13F filings with the SEC.

News

Stay updated on Polar Asset Management Partners Inc. with notifications on news.